Article: Antigen Express tests melanoma vaccine with Fred Hutchinson clinician.

2004 OCT 13 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corp. (GNBT) announced that its wholly owned subsidiary, Antigen Express, has entered into a collaboration with Dr. Cassian Yee of the Fred Hutchinson Cancer Research Center, Seattle, Washington, to test the potency of a novel peptide vaccine for melanoma in stimulating cancer patients' immune cells.

Previous animal studies with this vaccine demonstrated dramatically more potent immune stimulation compared with prior vaccines investigated in the clinic.

"The extensive experience of Dr. Yee in clinical immunotherapy and focus on novel therapeutic strategies for melanoma perfectly ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!